Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-38,629
Closed -$5.68M 116
2017
Q2
$5.68M Buy
38,629
+341
+0.9% +$51.4K 0.11% 63
2017
Q1
$6.37M Buy
38,288
+4,537
+13% +$761K 0.11% 60
2016
Q4
$5.36M Buy
33,751
+1,377
+4% +$210K 0.1% 59
2016
Q3
$4.92M Buy
32,374
+140
+0.4% +$21.2K 0.1% 66
2016
Q2
$4.68M Buy
32,234
+3,433
+12% +$491K 0.1% 67
2016
Q1
$4.17M Sell
28,801
-5,073
-15% -$648K 0.12% 71
2015
Q4
$4.46M Sell
33,874
-8,928
-21% -$1.2M 0.12% 70
2015
Q3
$5.93M Buy
42,802
+1,108
+3% +$164K 0.14% 67
2015
Q2
$6.48M Buy
41,694
+1,507
+4% +$242K 0.12% 76
2015
Q1
$6.17M Buy
40,187
+6,631
+20% +$1.01M 0.12% 70
2014
Q4
$5.15M Buy
33,556
+921
+3% +$147K 0.1% 76
2014
Q3
$5.92M Buy
32,635
+6,250
+24% +$1.14M 0.11% 76
2014
Q2
$4.57M Buy
26,385
+3,638
+16% +$655K 0.1% 73
2014
Q1
$4.19M Buy
22,747
+14,756
+185% +$2.6M 0.11% 70
2013
Q4
$1.43M Buy
7,991
+5,512
+222% +$951K 0.05% 107
2013
Q3
$439K Sell
2,479
-262
-10% -$47.6K 0.02% 129
2013
Q2
$501K Buy
+2,741
New +$534K 0.02% 123

Other funds holding IBM

Salient Capital Advisors's IBM Position: Q3 2017 in Review

Salient Capital Advisors sold out of IBM (IBM) in Q3 2017, closing a stake of 38,629 shares — an estimated $5.68M sold.

Salient Capital Advisors first reported a position in IBM in Q2 2013 and held it in 17 quarters. The position peaked at $6.48M in Q2 2015. 1,758 funds tracked by Wall St. Rank hold IBM as of Q3 2017.

  • Salient Capital Advisors reported no remaining IBM position as of Q3 2017 after selling out during the quarter.
  • Salient Capital Advisors sold 38,629 IBM shares in Q3 2017, an estimated $5.68M.
  • Salient Capital Advisors first reported a position in IBM in Q2 2013 and held it in 17 quarters.
  • Salient Capital Advisors's IBM position peaked at $6.48M in Q2 2015.
  • 1,758 funds tracked by Wall St. Rank held IBM as of Q3 2017.

Based on Salient Capital Advisors's 13F filing for Q3 2017, filed 6 Nov 2017.